BioSpace News Archive

Business

Stanford University Researchers Form Biotech to Develop Cannabis-Based Therapeutics

Researchers with Stanford University Jonathan Rothbard and Lawrence Steinman, formed Katexco Pharmaceuticals. Katexco will focus on developing oral therapies for inflammatory diseases based on cannabis and nicotine receptors.

October 24, 2018
·
3 min read
·
Mark Terry
Biotech Bay

Amgen Slashes Price of Repatha by 60% to Make the Drug More Accessible

Thousand Oaks-based Amgen will reduce the price of its anti-cholesterol drug Repatha by 60 percent to $5,850 per year as part of a move to improve affordability by lowering patient copays, the company announced Wednesday.

October 24, 2018
·
3 min read
·
Alex Keown
Business

Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week

Plenty of biotech companies will be releasing their third-quarter financial reports next week. Let’s take a quick look at some of these companies and their top stories they reported through 3Q2018.

October 24, 2018
·
5 min read
·
Mark Terry
Apogenix to Present at Five Upcoming October and November 2018 International Conferences

Apogenix announced today that company representatives will attend several upcoming international conferences. In a total of five presentations, Apogenix will give updates on its hexavalent TNF superfamily receptor agonists (HERA-ligands) as well as its phase III-ready lead drug candidate asunercept.

October 24, 2018
·
3 min read
Policy

Ministry of Health and Prevention to showcase smart health services at GITEX Technology Week 2018

Smart services to be showcased include electronic sick leave attestation, online permits for imported drugs, ‘Sanad &Rahma’ & electronic birth and death certificates

October 24, 2018
·
1 min read
Business

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

October 24, 2018
·
3 min read
Deals

Osmotica Pharmaceuticals plc Announces Pricing of Initial Public Offering

Osmotica Pharmaceuticals plc today announced the pricing of its initial public offering of 6,650,000 ordinary shares at a public offering price of $7.00 per share.

October 24, 2018
·
2 min read
Policy

The Best Career Advice for New Life Science Professionals

What do you wish someone would’ve told you at the beginning of your career? Most people reflect on their career development and think, ‘If only I knew then what I know now, I’d be farther along.’

October 24, 2018
·
3 min read
·
Porschia Parker
Policy

No Arrests in Murder of Apotex Founder and Wife Nearly One Year After

Bloomberg Businessweek published a deep-dive into the life of the Shermans and the issues surrounding their death. “No one knows who did it, or why, but everyone has a theory,” the article’s subhead reads.

October 24, 2018
·
2 min read
·
Alex Keown
Business

SIRIO Pharma opens multimillion gummy production plant[1] at new high-tech nutraceutical facility in Ma’anshan, China

The new ‘Centre of Excellence’ already boasts one of the world’s most advanced gummy production line designed to meet demand from global markets

October 24, 2018
·
3 min read